E. S. Aliev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
E. S. Aliev has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- A. V. Burlakova
Peoples’ Friendship University of Russia named after Patrice Lumumba. University Clinical Hospital named after V.V. Vinogradov
1 shared publication - Aleksandr Leonovich
Peoples’ Friendship University of Russia named after Patrice Lumumba. University Clinical Hospital named after V.V. Vinogradov
1 shared publication - Aleksey E. Klimov
Peoples’ Friendship University of Russia named after Patrice Lumumba
1 shared publication - Alexander Alekseevich Barkhudarov
Peoples’ Friendship University of Russia named after Patrice Lumumba
1 shared publication - D. G. Safronova
Peoples’ Friendship University of Russia named after Patrice Lumumba. University Clinical Hospital named after V.V. Vinogradov
1 shared publication - Mikhail Kosachenko
Peoples’ Friendship University of Russia named after Patrice Lumumba
1 shared publication
Latest Publications
- 26 March 2026
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 31 (1)
Indocyanine green dose ranging in laparoscopic cholecystectomy for acute calculous cholecystitis
Aim . To determine the optimal dose and timing of indocyanine green for fluorescein cholangiography in laparoscopic cholecystectomy for patients with acute calculous cholecystitis. Material and methods . From March 2024 to February 2025, a prospective, non-randomized study of indocyanine green for fluorescein cholangiography in laparoscopic cholecystectomy was conducted in 197 patients with acute cholecystitis. Various doses of indocyanine green (1.25–10 mg) were administered at various times prior to surgery: from 40 min to 6 h and intraoperatively. The fluorescence intensity, time of optimal mapping of hepatoduodenal ligament structures, and ability to safely perform surgery were assessed. Results. A dose of 5 mg indocyanine green provides an optimal effect within 3–6 h after administration. A dose of 2.5 mg indocyanine green shows the best effect within 1–3 h. When 1.25 mg of indocyanine green is administered 40–90 min before surgery, sufficient fluorescence can be achieved; however, adjustments to the equipment settings are required. Intraoperative 1.25–2.5 mg administration of the drug ensures a rapid examination of the ducts; however, accompanying hyperfluorescence hampers tissue differentiation. Conclusion . ICG fluorescence cholangiography is a safe and effective method of intraoperative navigation. Optimal doses are 2.5 and 5 mg administered 1–3 and 3–5 h before surgery, respectively. A dose of 1.25 mg may be administered pre- or intraoperatively for at least 1.5 h.
- 26 March 2026
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 31 (1)
Indocyanine green dose ranging in laparoscopic cholecystectomy for acute calculous cholecystitis
Aim . To determine the optimal dose and timing of indocyanine green for fluorescein cholangiography in laparoscopic cholecystectomy for patients with acute calculous cholecystitis. Material and methods . From March 2024 to February 2025, a prospective, non-randomized study of indocyanine green for fluorescein cholangiography in laparoscopic cholecystectomy was conducted in 197 patients with acute cholecystitis. Various doses of indocyanine green (1.25–10 mg) were administered at various times prior to surgery: from 40 min to 6 h and intraoperatively. The fluorescence intensity, time of optimal mapping of hepatoduodenal ligament structures, and ability to safely perform surgery were assessed. Results. A dose of 5 mg indocyanine green provides an optimal effect within 3–6 h after administration. A dose of 2.5 mg indocyanine green shows the best effect within 1–3 h. When 1.25 mg of indocyanine green is administered 40–90 min before surgery, sufficient fluorescence can be achieved; however, adjustments to the equipment settings are required. Intraoperative 1.25–2.5 mg administration of the drug ensures a rapid examination of the ducts; however, accompanying hyperfluorescence hampers tissue differentiation. Conclusion . ICG fluorescence cholangiography is a safe and effective method of intraoperative navigation. Optimal doses are 2.5 and 5 mg administered 1–3 and 3–5 h before surgery, respectively. A dose of 1.25 mg may be administered pre- or intraoperatively for at least 1.5 h.